Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-184-4 | CAS number: 53-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- In vivo study that was performed before 10 May 2017
Test material
- Reference substance name:
- Nadide
- EC Number:
- 200-184-4
- EC Name:
- Nadide
- Cas Number:
- 53-84-9
- Molecular formula:
- C21H27N7O14P2
- IUPAC Name:
- nadide
- Test material form:
- other: crystalline powder
- Details on test material:
- - Physical state: crystalline powder
- Analytical purity: 98-area%
- Storage condition of test material: 2 - 8 °C, protected from light
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Crl:HA - Guinea Pigs
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Age at study initiation: approximately 4 weeks
- Weight at study initiation: 353- 399 g
- Housing: Semi barrier in an air-conditioned room
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum):ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 oc
- Humidity (%): 55+/- 10%
- Air changes (per hr): at least I 0 x I hour
- Photoperiod (hrs dark / hrs light) :Artificial light, sequence being 12 hours light, 12 hours dark
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: vaseline
- Concentration / amount:
- 2.5% and 50%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 2.5% and 50%
- No. of animals per dose:
- Number of animals in the test group: 10
Number of animals in the negative-control group: 5
Number of animals in the dose range finding study: 3 - Details on study design:
- RANGE FINDING TESTS:
For the justification of dose levels a preliminary test was performed.
1 animal was treated intradermally with concentrations of 5% and 2.5% of the test item (dissolved in physiological saline 0.9% NaCl)
1 animal was treated topically with concentrations of 50% and 25% of the test item (suspended in vaseline), for 24 hours.
1 animal was treated topically with concentrations of 50% and 25% of the test item (suspended in vaseline), for 48 hours.
MAIN STUDY
A. INDUCTION EXPOSURE
induction: First Stage, lntradermal lnjection
Three pairs of intradermal injections of 0.1 mL volume were given in the shoulder region which was cleared of hair by clipping so that one of each par lies on each side of the midline.
Test Group: Day 0
Injection I: a I: I mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 2.5% the test item in physiological saline 0.9% NaCl
Injection 3: 2.5% the test item formulated in a I :I mixture (v/v) FCA/physiological
saline 0.9% NaCl
Control Group: Day 0
Injection I: a I: I mixture (v/v) FCA/physiological saline 0.9% NaCI
Injection 2: 100% physiological saline 0.9% NaCl
Injection 3: a 50% (v/v) formulation of physiological saline 0.9% NaCl in a 1:1 (v/v)
mixture FCA/physiological saline 0.9% NaCl
Injections I and 2 were given close to each other and nearest to the head, while
injection 3 was given toward the caudal part of the test area.
11. 7. Induction: Second Stage, Topical Application
Test Group and Control Group: Day 6
Approximately twenty-four hours before the topical application the test area was
painted with 0.5 g of I 0% sodium Iaury! sulphate in vase line after close clipping in
order to create a local irritation.
Test Group: Day 7
The test item was suspended in vaseline at a concentration of 50%. A patch was fully
loaded with 0.5 g of the prepared test item. Then it was applied to the test area and held
in contact with the help of an occlusive dressing for 48 hours.
Control Group: Day 7
A patch was fully loaded with 0.5 g ofvaseline. Then it was applied to the test area and
held in contact with the help of an occlusive dressing for 48 hours.
B. CHALLENGE EXPOSURE
Challenge: Topical Application
The flanks of treated and control animals were cleared of hair by close-clipping.
Test Group and Control Group: Day 20
The test item was suspended in vaseline at a concentration of 50%. A patch, loaded with
0.5 g of the prepared test item was applied to the left flank of the animals and a patch
loaded with 0.5 g of the vehicle to the right flank (intraspecific control). The patches
were held in contact with the help of an occlusive dressing for 24 hours.
The application area was not rinsed.
OTHER: - Positive control substance(s):
- yes
- Remarks:
- mercaptobenzothiazole, purity> 98%
Results and discussion
- Positive control results:
- The sensitisation rate after application of the positive-control substance mercaptobenzothiazole (15% in vaseline) was IOO%, confirming the reliability of the test system.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 15%
- No. with + reactions:
- 5
- Total no. in group:
- 5
Any other information on results incl. tables
Challenge Concentrations of Test Substance: 50% | |||||||||
Number of animals showing skin reaction after:
|
|||||||||
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Conclusions:
- Under the conditions of the present study it can be stated that the test item b-Nicotinamide-adenine Dinucleotide II (nadide) caused no reactions
identified as sensitisation at the tested concentration. According to the EC criteria for classification and labelling requirements for dangerous
substances and preparations labelling is not necessary. - Executive summary:
Skin sensitisation potential of Nadide was tested using the Guinea Pig Maximisation Test in accordance with OECD guideline 406.
A preliminary test was used to determine the concentrations to be used. The concentrations chosen for the main test were: 2.5% for the intradermal induction; 50% for the dermal induction and 50% for the challenge concentration. 10 female guinea pigs (Crl:HA) were used as test group and 5 animals in the negative control group. Under the conditions of the present study it can be stated that the test item b-Nicotinamide-adenine Dinucleotide II (nadide) caused no reactions
identified as sensitisation at the tested concentration. According to the EC criteria for classification and labelling requirements for dangerous substances and preparations labelling is not necessary. The substance is also considered unclassified according to GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.